Prostaglandin E2 (PGE2) synthesized by tumor cells and antitumor activity in T cells have been shown to decrease via IL-6, chemokine ligand 1 (C-X-C motif, CXCL1) and granulocyte colony stimulating factor (G-CSF) pathways [131]. This evidence concerns the gene CSF3 and neoplasm.